1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Neoplasms, Lung: new trials by email Literature Review of Neoplasms, Lung trials Research Report on Neoplasms, Lung
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations Erlotinib, Docetaxel, Cisplatin - Neoplasms, Lung, Carcinoma, Non-Small Cell Lung | Phase 2 | Unknown | Chinese PLA General Hospital | 60 | 2010-06-01 | 2010-05-27 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1)
Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Cisplatin (1) · Docetaxel (1) · Erlotinib Hydrochloride (1)
Chinese PLA General Hospital (1)
China (1)